مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

942
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EFFECTS OF ALLOPURINOL ON THE LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH LEFT VENTRICULAR FAILURE

Pages

  104-108

Abstract

 Background: Efficacy of XANTHINE OXIDASE INHIBITORS on the improvement of cardiac performance is not clearly defined. This study was designed to study the efficacy of ALLOPURINOL on the improvement of LEFT VENTRICULAR EJECTION FRACTION (LVEF) in patients with chronic HEART FAILURE.Methods: A randomized, double blind, placebo controlled CLINICAL TRIAL was performed on two groups of patients suffered from class II to III HEART FAILURE of New York Heart Association classification. 16 cases were in intervention group who intake ALLOPURINOL (100 mg/day in the first three days, 200 mg/day in the second three days and 300 mg/day for one month); 15 cases were in control group and intaked placebo like case group. LEFT VENTRICULAR EJECTION FRACTION was measured by echocardiography with Simpson's method and compared before and after the intervention. Findings: The mean of LVEF before and after intervention, in case group were 38.8±9.9 and 41.9±9.7 respectively (p<0.05); and in control group were 37.05±5.7 and 37.1±5.6 respectively (p>0.05). In intervention group EF was increased 3.1% from base level.Conclusion: ALLOPURINOL can be effective in improvement of cardiac performance. However its clinical use for HEART FAILURE patients needs to be approved by more trials, in various situations and longer periods.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    HADIZADEH, M., GARAK YARAGHI, M., SADEGHI, M., HADIZADEH, F., & NESHATDOUST, B.. (2007). EFFECTS OF ALLOPURINOL ON THE LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH LEFT VENTRICULAR FAILURE. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 25(85), 104-108. SID. https://sid.ir/paper/50110/en

    Vancouver: Copy

    HADIZADEH M., GARAK YARAGHI M., SADEGHI M., HADIZADEH F., NESHATDOUST B.. EFFECTS OF ALLOPURINOL ON THE LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH LEFT VENTRICULAR FAILURE. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2007;25(85):104-108. Available from: https://sid.ir/paper/50110/en

    IEEE: Copy

    M. HADIZADEH, M. GARAK YARAGHI, M. SADEGHI, F. HADIZADEH, and B. NESHATDOUST, “EFFECTS OF ALLOPURINOL ON THE LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH LEFT VENTRICULAR FAILURE,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 25, no. 85, pp. 104–108, 2007, [Online]. Available: https://sid.ir/paper/50110/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top